Lord Kamall Alert Sample


Alert Sample

View the Parallel Parliament page for Lord Kamall

Information since 17 Jun 2022, 4:51 p.m.


Speeches
Lord Kamall speeches from: Cannabis: Medicinal Use
Lord Kamall contributed 11 speeches (1,116 words)
Tuesday 12th July 2022 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: General Practitioners: Shortage
Lord Kamall contributed 4 speeches (500 words)
Tuesday 12th July 2022 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: Coronavirus: New Cases
Lord Kamall contributed 17 speeches (1,479 words)
Monday 11th July 2022 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: Health Improvement and Food Production
Lord Kamall contributed 3 speeches (3,119 words)
Thursday 7th July 2022 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: Bread and Flour Regulations: Folic Acid
Lord Kamall contributed 13 speeches (1,105 words)
Wednesday 6th July 2022 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: Thyroid Patients: Liothyronine
Lord Kamall contributed 7 speeches (656 words)
Wednesday 6th July 2022 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: Paramedic Services
Lord Kamall contributed 8 speeches (878 words)
Monday 4th July 2022 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: Mental Health: Advertising and Body Image
Lord Kamall contributed 9 speeches (1,041 words)
Thursday 30th June 2022 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: Pharmacy (Responsible Pharmacists, Superintendent Pharmacists etc.) Order 2022
Lord Kamall contributed 3 speeches (2,104 words)
Tuesday 28th June 2022 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: Draft Mental Health Bill
Lord Kamall contributed 11 speeches (2,973 words)
Tuesday 28th June 2022 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: National Health Service (Integrated Care Boards: Exceptions to Core Responsibility) Regulations 2022
Lord Kamall contributed 1 speech (20 words)
Monday 27th June 2022 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: Diabetic Prevention Programme
Lord Kamall contributed 12 speeches (994 words)
Thursday 23rd June 2022 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: Polio
Lord Kamall contributed 11 speeches (1,579 words)
Thursday 23rd June 2022 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: Social Care: Adults
Lord Kamall contributed 11 speeches (1,108 words)
Wednesday 22nd June 2022 - Lords Chamber
Department of Health and Social Care
Lord Kamall speeches from: National Health Service (Integrated Care Boards: Exceptions to Core Responsibility) Regulations 2022
Lord Kamall contributed 4 speeches (1,174 words)
Monday 20th June 2022 - Grand Committee
Department of Health and Social Care



Lord Kamall mentioned

Select Committee Documents
Monday 18th July 2022
Written Evidence - Department of Health and Social Care
DDA0073 - The right to privacy: digital data

The right to privacy: digital data - Science and Technology Committee

Found: Follow up Written Evidence Submitted by Lord Kamall, Minister for Technology, Innovation and Life Sciences



Written Answers
Medical Records: Gender Recognition
Asked by: Lord Clement-Jones (Liberal Democrat - Life peer)
Friday 5th August 2022

Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to the Written Answers by Lord Kamall on 24 May (HL476 and HL475), what is the legal underpinning for the policy set out in the Gender Identity Toolkit for General Practice that only gender, not sex and gender, are included on medical records.

Answered by Lord Kamall - Parliamentary Under-Secretary (Department of Health and Social Care)

The Gender Recognition Act 2004 provides additional rights and safeguards for those with a Gender Recognition Certificate (GRC), such as making it an offence to disclose protected information. This includes information pertaining to the previously recorded sex of a person who holds a GRC where that information has been obtained in an official capacity and the person has not consented to its disclosure, subject to limited exceptions.

The Gender Identity Toolkit for General Practice is made available by the Institute of General Practice Management, Indigo Gender Service, Practice Index and Pride in Practice. However, it is not Government guidance. The Toolkit provides voluntary information to general practices on the administration of changes to medical records and makes reference to the Gender Recognition Act.

Medical Records: Gender Recognition
Asked by: Lord Clement-Jones (Liberal Democrat - Life peer)
Friday 5th August 2022

Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to the Written Answers by Lord Kamall on 24 May (HL476 and HL475), what is the policy for recording the gender of people who self-identify as non-binary in medical records; and what is the legal underpinning for this policy.

Answered by Lord Kamall - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government continues to consider emerging data and research on the experiences of non-binary people to understand how future policy can be developed. In general, the National Health Service identifies individuals as male or female via NHS numbers and medical records. This aligns with the Gender Recognition Act 2004 which refers to two sexes: male and female. NHS bodies must always consider any legal obligations under the Equality Act 2010 and compliance with the European Convention on Human Rights in respect of those who identify as non-binary.

Ophthalmic Services: Special Educational Needs
Asked by: Baroness Finlay of Llandaff (Crossbench - Life peer)
Tuesday 26th July 2022

Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 11 July (HL1271), how many children attending day special schools access eye tests through the domiciliary scheme.

Answered by Lord Kamall - Parliamentary Under-Secretary (Department of Health and Social Care)

The information requested is not collected centrally.

Medical Records: Gender Recognition
Asked by: Lord Clement-Jones (Liberal Democrat - Life peer)
Tuesday 26th July 2022

Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to the Written Answers by Lord Kamall on 24 May (HL476 and HL475), what assessment they have made of the risks to (1) patients, and (2) medical professionals, that might arise as a result of the policy on recording gender set out in the Gender Identity Toolkit for General Practice.

Answered by Lord Kamall - Parliamentary Under-Secretary (Department of Health and Social Care)

No formal risk assessment has been made.

Gender Recognition
Asked by: Lord Clement-Jones (Liberal Democrat - Life peer)
Tuesday 26th July 2022

Question to the Department of Health and Social Care:

To ask Her Majesty's Government further to the Written Answers by Lord Kamall on 24 May (HL476 and HL475), what assessment they have made of the (1) clarity, and (2) inclusivity, of using the language “people with cervixes” in the Gender Identity Toolkit for General Practice.

Answered by Lord Kamall - Parliamentary Under-Secretary (Department of Health and Social Care)

No specific assessment has been made. The Toolkit is made available by the Institute of General Practice Management, Indigo Gender Service, Practice Index and Pride in Practice. It is designed to improve the knowledge of general practice teams when providing inclusive and equitable care to transgender and non-binary patients.

Medical Records: Gender Recognition
Asked by: Lord Clement-Jones (Liberal Democrat - Life peer)
Tuesday 26th July 2022

Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to the Written Answers by Lord Kamall on 24 May (HL476 and HL475), how medical professionals are held to account for any negative consequences that arise from how they have recorded a patient’s gender.

Answered by Lord Kamall - Parliamentary Under-Secretary (Department of Health and Social Care)

All regulated healthcare professionals are required to register with the relevant professional regulator, such as the General Medical Council, in order to practice in the United Kingdom. These regulators determine the standards which registered professionals must meet and the professional values, knowledge, skills and behaviours required. Regulators are independent bodies and can take action to restrict the practise of healthcare professionals who fail to meet the expected standards.

Bread and Flour: Folic Acid
Asked by: Lord Rooker (Labour - Life peer)
Wednesday 20th July 2022

Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to the answer by Lord Kamall on 6 July (HL Deb cols 1001–2) regarding the scientific evidence available regarding folic fortification, whether they will publish the science brief referred to by Lord Kamall referencing heliocentrism versus geocentrism.

Answered by Lord Kamall - Parliamentary Under-Secretary (Department of Health and Social Care)

The scientific contestation referred to is summarised in the paper Folic acid and neural tube defects: Discovery, debate and the need for policy change by Professor Nicholas Wald. Professor Wald asserts that the United Kingdom should pursue a higher level of fortification than would be permitted by the UK’s Tolerable Upper Level (TUL). A copy of the paper is attached.

The Government and its independent scientific advisory bodies have agreed that fortification of non-wholemeal wheat flour with folic acid, at a level informed by the guidance for supplemental intake of folic acid intake advised by the UK Expert Group on Vitamins and Minerals, is a safe and effective measure to reduce the number of neural tube defects (NTDs).

This view is supported by the Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (COT) and by the Scientific Advisory Committee on Nutrition (SACN). In 2018 COT published Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment: COT position paper on the current upper level for folic acid intake in response to a previous paper by Professor Wald, addressing the technical points raised in objection to the TUL and continuing to recommend its use. A copy of this paper is attached.

Deaths associated with high levels of folic acid refers to potential unintended harms which may arise following the fortification of flour with folic acid, such as an increase in the potential masking of vitamin B12 deficiency or pernicious anaemia where the deficiency can cause permanent neurological damage which can lead to death if untreated.

No recent discussions have taken place with countries which have implemented folic acid fortification on unintended consequences of the policy. However, evidence from a number of countries, including those which have implemented folic acid fortification policies, was considered by the SACN and COT to establish the safety and efficacy of fortifying food with folic acid. Analysis by COT and the SACN found that there was insufficient evidence to discount a number of potential risks at very levels of fortification.

While there is no specific scientific briefing relating to the debate between heliocentrism versus geocentrism, as I stated in the debate, we will routinely review the policy post-implementation to ensure it meets the objective of reducing NTDs while avoiding any unintended consequences. The forthcoming consultation will outline the proposed fortification levels with the supporting scientific rationale.

Bread and Flour: Folic Acid
Asked by: Lord Rooker (Labour - Life peer)
Wednesday 20th July 2022

Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to the answer by Lord Kamall on 6 July (HL Deb col 1000), whether they will give details of the cases where people “have died because of high levels of folic acid”.

Answered by Lord Kamall - Parliamentary Under-Secretary (Department of Health and Social Care)

The scientific contestation referred to is summarised in the paper Folic acid and neural tube defects: Discovery, debate and the need for policy change by Professor Nicholas Wald. Professor Wald asserts that the United Kingdom should pursue a higher level of fortification than would be permitted by the UK’s Tolerable Upper Level (TUL). A copy of the paper is attached.

The Government and its independent scientific advisory bodies have agreed that fortification of non-wholemeal wheat flour with folic acid, at a level informed by the guidance for supplemental intake of folic acid intake advised by the UK Expert Group on Vitamins and Minerals, is a safe and effective measure to reduce the number of neural tube defects (NTDs).

This view is supported by the Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (COT) and by the Scientific Advisory Committee on Nutrition (SACN). In 2018 COT published Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment: COT position paper on the current upper level for folic acid intake in response to a previous paper by Professor Wald, addressing the technical points raised in objection to the TUL and continuing to recommend its use. A copy of this paper is attached.

Deaths associated with high levels of folic acid refers to potential unintended harms which may arise following the fortification of flour with folic acid, such as an increase in the potential masking of vitamin B12 deficiency or pernicious anaemia where the deficiency can cause permanent neurological damage which can lead to death if untreated.

No recent discussions have taken place with countries which have implemented folic acid fortification on unintended consequences of the policy. However, evidence from a number of countries, including those which have implemented folic acid fortification policies, was considered by the SACN and COT to establish the safety and efficacy of fortifying food with folic acid. Analysis by COT and the SACN found that there was insufficient evidence to discount a number of potential risks at very levels of fortification.

While there is no specific scientific briefing relating to the debate between heliocentrism versus geocentrism, as I stated in the debate, we will routinely review the policy post-implementation to ensure it meets the objective of reducing NTDs while avoiding any unintended consequences. The forthcoming consultation will outline the proposed fortification levels with the supporting scientific rationale.

Bread and Flour: Folic Acid
Asked by: Lord Rooker (Labour - Life peer)
Wednesday 20th July 2022

Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to the answer by Lord Kamall on 6 July (HL Deb col 999), whether they will cite the “scientific contestation” referred to concerning folic acid fortification as part of the Bread and Flour Regulations review.

Answered by Lord Kamall - Parliamentary Under-Secretary (Department of Health and Social Care)

The scientific contestation referred to is summarised in the paper Folic acid and neural tube defects: Discovery, debate and the need for policy change by Professor Nicholas Wald. Professor Wald asserts that the United Kingdom should pursue a higher level of fortification than would be permitted by the UK’s Tolerable Upper Level (TUL). A copy of the paper is attached.

The Government and its independent scientific advisory bodies have agreed that fortification of non-wholemeal wheat flour with folic acid, at a level informed by the guidance for supplemental intake of folic acid intake advised by the UK Expert Group on Vitamins and Minerals, is a safe and effective measure to reduce the number of neural tube defects (NTDs).

This view is supported by the Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (COT) and by the Scientific Advisory Committee on Nutrition (SACN). In 2018 COT published Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment: COT position paper on the current upper level for folic acid intake in response to a previous paper by Professor Wald, addressing the technical points raised in objection to the TUL and continuing to recommend its use. A copy of this paper is attached.

Deaths associated with high levels of folic acid refers to potential unintended harms which may arise following the fortification of flour with folic acid, such as an increase in the potential masking of vitamin B12 deficiency or pernicious anaemia where the deficiency can cause permanent neurological damage which can lead to death if untreated.

No recent discussions have taken place with countries which have implemented folic acid fortification on unintended consequences of the policy. However, evidence from a number of countries, including those which have implemented folic acid fortification policies, was considered by the SACN and COT to establish the safety and efficacy of fortifying food with folic acid. Analysis by COT and the SACN found that there was insufficient evidence to discount a number of potential risks at very levels of fortification.

While there is no specific scientific briefing relating to the debate between heliocentrism versus geocentrism, as I stated in the debate, we will routinely review the policy post-implementation to ensure it meets the objective of reducing NTDs while avoiding any unintended consequences. The forthcoming consultation will outline the proposed fortification levels with the supporting scientific rationale.

Medical Treatments
Asked by: Baroness Masham of Ilton (Crossbench - Life peer)
Monday 18th July 2022

Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 17 June (HL645), whether an agenda for NHS England's Clinical Priorities Advisory Group's next meeting has been finalised; and if so, when it will be shared with relevant stakeholders.

Answered by Lord Kamall - Parliamentary Under-Secretary (Department of Health and Social Care)

The agenda has been finalised and made available to relevant stakeholders.

Medical Treatments
Asked by: Baroness Masham of Ilton (Crossbench - Life peer)
Monday 18th July 2022

Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 17 June (HL645), whether an agenda for NHS England's Clinical Priorities Advisory Group's next meeting has been finalised; and if so, when the agenda will be shared with stakeholders.

Answered by Lord Kamall - Parliamentary Under-Secretary (Department of Health and Social Care)

The agenda has been finalised and made available to relevant stakeholders.

Hartismere Hospital: Community Diagnostic Centres
Asked by: Lord Framlingham (Conservative - Life peer)
Monday 18th July 2022

Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 28 June (HL985), whether Hartismere hospital in Suffolk is under consideration as a community diagnostic centre.

Answered by Lord Kamall - Parliamentary Under-Secretary (Department of Health and Social Care)

There are currently no existing community diagnostic centres (CDCs) in Suffolk and potential locations remain under review. NHS England’s discussions with local integrated care systems, diagnostic networks and primary care services have considered Hartismere Hospital as a potential site for a CDC. However, these locations will be determined alongside wider system plans for providing more accessible diagnostics to the local population, including potential sites in Ipswich and Newmarket.

Community Diagnostic Centres: Suffolk
Asked by: Lord Framlingham (Conservative - Life peer)
Monday 18th July 2022

Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 28 June  (HL985), which community diagnostic centres have already been identified in Suffolk and which are under consideration.

Answered by Lord Kamall - Parliamentary Under-Secretary (Department of Health and Social Care)

There are currently no existing community diagnostic centres (CDCs) in Suffolk and potential locations remain under review. NHS England’s discussions with local integrated care systems, diagnostic networks and primary care services have considered Hartismere Hospital as a potential site for a CDC. However, these locations will be determined alongside wider system plans for providing more accessible diagnostics to the local population, including potential sites in Ipswich and Newmarket.

Health Professions: Recruitment
Asked by: Lord Bishop of St Albans (Bishops - Bishops)
Monday 18th July 2022

Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 27 June (HL1046), what plans they have to record data on the number of health care professionals who were hired from countries graded as red by the World Health Organisation.

Answered by Lord Kamall - Parliamentary Under-Secretary (Department of Health and Social Care)

We have no plans to do so.

We collate data from published sources to monitor the patterns of staff joining the National Health Service who have trained outside the United Kingdom. This includes data from the the Nursing and Midwifery Council’s register and the Electronic Staff Record’s information on the nationality of staff.

NHS: Incentives
Asked by: Baroness Finlay of Llandaff (Crossbench - Life peer)
Friday 15th July 2022

Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 22 June (HL620), why the decision was made to remove central funding of the local clinical excellence awards scheme from 31 March; what assessment they have made of the impact this change will have on clinical academies; and why the planned amendment of Schedule 30 to include clinical academies within the group with a contractual entitlement to apply for such awards was abandoned.

Answered by Lord Kamall - Parliamentary Under-Secretary (Department of Health and Social Care)

From 2018 to March 2022, the Department was involved in tripartite negotiations between employers, the British Medical Association (BMA) and the Hospital Consultants and Specialists Association to reform local clinical excellence awards. However, the proposal was rejected by the executive committees of the trades unions and the negotiations concluded without agreement.

National Health Service trusts are therefore reverting to the arrangements in Schedule 30 of the consultant contract, agreed with the BMA in 2018. This does not alter the funding and eligibility position for clinical academics and represents a continuation of existing provisions.

Coronavirus: Screening
Asked by: Lord Hunt of Kings Heath (Labour - Life peer)
Monday 4th July 2022

Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 17 May (HL71), what is the average rate of staff turnover within the Coronavirus Test Device Approval team since its implementation; and what steps they are taking to ensure that this does not affect the ability of the review team, including new scientific advisors, to address the ongoing COVID diagnostics application backlog.

Answered by Lord Kamall - Parliamentary Under-Secretary (Department of Health and Social Care)

We are unable to provide the information requested on average staff turnover as it is not held in the format requested and could only be obtained at disproportionate cost.

The number of scientific advisors has remained stable. There are six new posts currently advertised to recruit permanent civil servants as scientific advisors, to replace contractors in these roles. In addition, organisational learning is being recorded to ensure continuity, including a new management information system and appropriate handover periods as staff are replaced.



Non-Departmental Publications - Transparency
Jul. 19 2022
Medicines and Healthcare products Regulatory Agency
Source Page: Human Medicines Regulations 2012 Advisory Bodies Annual Report 2021
Document: Human Medicines Regulations 2012 Advisory Bodies Annual Report 2021 (PDF)
Transparency

Found: James Morris MP, on behalf of Lord Kamall 7 COMMISSION O N HUMAN MEDICINES ANNUAL REPORT

Jul. 19 2022
Medicines and Healthcare products Regulatory Agency
Source Page: Human Medicines Regulations 2012 Advisory Bodies Annual Report 2021
Document: Human Medicines Regulations 2012 Advisory Bodies Annual Report 2021: accessible PDF version (PDF)
Transparency

Found: James Morris MP, on behalf of Lord Kamall 8 COMMISSION ON HUMAN MEDICINES ANNUAL REPORT



Deposited Papers
Monday 1st August 2022
Department of Health and Social Care
Source Page: Letter dated 21/07/2022 from Lord Kamall to Peers regarding questions raised during a briefing on the Draft Mental Health Bill: UK-wide extent, how the reforms will apply to children and young people, genetic testing, crossover between the revised MCA (Mental Capacity Act) Code of Practice and the Mental Health Act reforms, safeguards to protect patients from a nominated person, and addressing the impact of poor physical health on mental health. 2p.
Document: MHB__roundtable_follow-up_letter_21072022.pdf (PDF)

Found: Letter dated 21/07/2022 from Lord Kamall to Peers regarding questions raised during a briefing on the

Wednesday 20th July 2022
Department of Health and Social Care
Source Page: Letter dated 18/07/2022 from Lord Kamall to Peers regarding issues raised in the Draft Pharmacy (Responsible Pharmacist Superintendent Pharmacist) Order 2022 debate: dispensing doctors, the rate of closures of community pharmacies and the timelines for the introduction of new regulations under the Draft Order. 2p.
Document: 2022_07_18_letter_to_Members_of_the_House_of_Lords_SK_.pdf (PDF)

Found: Letter dated 18/07/2022 from Lord Kamall to Peers regarding issues raised in the Draft Pharmacy (Responsible

Thursday 14th July 2022
Department of Health and Social Care
Source Page: Letter dated 08/07/2022 from Lord Kamall to Peers regarding questions raised following the Oral Statement on the Draft Mental Health Bill: recommendations not accepted, £150 million funding, young people refusing treatment, suicide prevention, old building stock, mental health support for new parents, pre-legislative scrutiny committee. 3p.
Document: Draft_Mental_Health_Bill_Letter_to_Peers.pdf (PDF)

Found: Letter dated 08/07/2022 from Lord Kamall to Peers regarding questions raised following the Oral Statement